Arax Advisory Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $272K | Sell |
1,021
-533
| -34% | -$144K | 0.01% | 924 |
|
|
2025
Q4 | $390K | Sell |
1,554
-3,173
| -67% | -$843K | 0.01% | 706 |
|
|
2025
Q3 | $1.36M | Buy |
4,727
+4,022
| +570% | +$1.08M | 0.02% | 556 |
|
|
2025
Q2 | $202K | Buy |
705
+129
| +22% | +$31.4K | 0.01% | 653 |
|
|
2025
Q1 | $134K | Sell |
576
-138
| -19% | -$33.5K | 0.01% | 637 |
|
|
2024
Q4 | $164K | Buy |
714
+61
| +9% | +$14K | 0.01% | 541 |
|
|
2024
Q3 | $146K | Sell |
653
-8
| -1% | -$1.76K | 0.01% | 409 |
|
|
2024
Q2 | $135K | Buy |
661
+241
| +57% | +$49K | 0.01% | 413 |
|
|
2024
Q1 | $91.8K | Sell |
420
-3
| -0.7% | -$661 | 0.01% | 404 |
|
|
2023
Q4 | $96.1K | Buy |
423
+1
| +0.2% | +$210 | 0.01% | 386 |
|
|
2023
Q3 | $84.8K | Sell |
422
-166
| -28% | -$35K | 0.01% | 377 |
|
|
2023
Q2 | $122K | Sell |
588
-96
| -14% | -$18.6K | 0.02% | 316 |
|
|
2023
Q1 | $135K | Sell |
684
-6
| -0.9% | -$1.24K | 0.02% | 298 |
|
|
2022
Q4 | $140K | Buy |
690
+1
| +0.1% | +$195 | 0.02% | 279 |
|
|
2022
Q3 | $121K | Sell |
689
-92
| -12% | -$18.8K | 0.02% | 282 |
|
|
2022
Q2 | $157K | Sell |
781
-665
| -46% | -$142K | 0.02% | 248 |
|
|
2022
Q1 | $327K | Sell |
1,446
-17
| -1% | -$4K | 0.04% | 169 |
|
|
2021
Q4 | $395K | Sell |
1,463
-71
| -5% | -$17.6K | 0.05% | 143 |
|
|
2021
Q3 | $371K | Sell |
1,534
-2
| -0.1% | -$504 | 0.05% | 132 |
|
|
2021
Q2 | $364K | Buy |
+1,536
| New | +$350K | 0.05% | 138 |
|
|
2020
Q4 | $277K | Buy |
1,582
+295
| +23% | +$51K | 0.04% | 155 |
|
|
2020
Q3 | $208K | Buy |
1,287
+483
| +60% | +$76.5K | 0.04% | 183 |
|
|
2020
Q2 | $115K | Hold |
804
| – | – | 0.02% | 242 |
|
|
2020
Q1 | $87K | Sell |
804
-43
| -5% | -$6.2K | 0.02% | 256 |
|
|
2019
Q4 | $123K | Buy |
847
+18
| +2% | +$2.6K | 0.04% | 223 |
|
|
2019
Q3 | $120K | Buy |
829
+35
| +4% | +$5.11K | 0.04% | 220 |
|
|
2019
Q2 | $118K | Buy |
+794
| New | +$111K | 0.04% | 209 |
|
|
2018
Q4 | $64K | Sell |
594
-57
| -9% | -$7.64K | 0.03% | 242 |
|
|
2018
Q3 | $97K | Sell |
651
-4
| -0.6% | -$608 | 0.04% | 202 |
|
|
2018
Q2 | $101K | Buy |
655
+301
| +85% | +$45.4K | 0.04% | 153 |
|
|
2018
Q1 | $49K | Sell |
354
-100
| -22% | -$14.7K | 0.03% | 205 |
|
|
2017
Q4 | $62K | Sell |
454
-6
| -1% | -$793 | 0.03% | 195 |
|
|
2017
Q3 | $59K | Buy |
460
+35
| +8% | +$4.67K | 0.03% | 200 |
|
|
2017
Q2 | $56K | Buy |
425
+32
| +8% | +$3.92K | 0.03% | 216 |
|
|
2017
Q1 | $48K | Buy |
393
+89
| +29% | +$10.5K | 0.02% | 211 |
|
|
2016
Q4 | $34K | Buy |
+304
| New | +$33.8K | 0.02% | 208 |
|
Other funds holding LH
VCM
VPM
Arax Advisory Partners's LH Position: Q1 2026 in Review
Arax Advisory Partners reduced its Labcorp (LH) stake by 34% in Q1 2026, selling an estimated $144K and leaving 1,021 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #924.
Arax Advisory Partners first reported a position in LH in Q4 2016 and has held it in 36 quarters since. The position peaked at $1.36M in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Arax Advisory Partners held 1,021 shares of Labcorp worth $272K as of Q1 2026.
- Arax Advisory Partners sold 533 Labcorp shares in Q1 2026, an estimated $144K.
- Labcorp made up 0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #924 holding.
- Arax Advisory Partners first reported a position in Labcorp in Q4 2016 and has held it in 36 quarters since.
- Arax Advisory Partners's Labcorp position peaked at $1.36M in Q3 2025.
- 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.